Trandolapril labels and packages: Difference between revisions

Revision as of 21:56, 18 February 2014

Trandolapril
MAVIC^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Trandolapril
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2]

Adapted from the FDA Package Insert.

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}} {{AM}}
-<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MAVIK (TRANDOLAPRIL) TABLET [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad67ea2-409c-4f52-a9b8-38216209609a | publisher =  | date =  | accessdate = }}</ref>
+{|
+| [[File:dd3.png|800px|thumb]]
+|}
+{|
+| [[File:dd4.png|800px|thumb]]
+|}
+{|
+| [[File:dd5.png|800px|thumb]]
+|}<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = MAVIK (TRANDOLAPRIL) TABLET [ABBVIE INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5ad67ea2-409c-4f52-a9b8-38216209609a | publisher =  | date =  | accessdate = }}</ref>
 ==References==